Patent · US Active

Diagnostic methods for T cell therapy

US11779601B2 · kind B2 · utility

1Cited by
6References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 27, 2016
Grant dateOct 10, 2023
Priority date
Expiry dateMay 27, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/5443
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods of increasing the efficacy of a T cell therapy in a patient in need thereof. The invention includes methods of identifying a patient who would respond well to a T cell therapy or conditioning a patient prior to a T cell therapy so that the patient responds well to a T cell therapy. The conditioning involves administering one or more preconditioning agents prior to a T cell therapy and identifying biomarker cytokines prior to administering a T cell therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.